ARCHIVES

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987

Statistics Review Shows Improved Mortality Under 65, Through 1986

January 19, 1990

More Than 300 request RFP for New Community Oncology Program

May 25, 1979

ASCO Guideline Aims To Improve Hormone Receptor Testing

April 23, 2010

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013